IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q2 2024 Holdings

Filed 2024-08-13 | 11 holdings | $77.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$30.8M6,164,54839.9%
Invivyd Inc(IVVD)COM00534A102$10.2M9,248,25013.2%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$8.3M385,68010.8%
Fractyl Health Inc(GUTS)COM35168W103$7.9M1,856,11710.3%
Springworks Therapeutics IncCOM85205L107$4.2M110,4005.4%
Silence Therapeutics PLC(SLN)ADS82686Q101$3.5M185,1004.6%
Bridgebio Pharma Inc(BBIO)COM10806X102$3.1M121,2004.0%
Curis Inc(CRIS)COM231269309$2.9M421,9513.8%
TG Therapeutics Inc(TGTX)COM88322Q108$2.9M161,6003.7%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$1.8M67,4002.3%
Proqr Thrapeutics N VSHS EURON71542109$1.7M1,019,4982.2%